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Abstract | Maintenance of genome stability requires control over the expression of transposable 
elements (TEs), whose activity can have substantial deleterious effects on the host. Chemical 
modification of DNA is a commonly used strategy to achieve this, and it has long been argued that 10 
the emergence of 5-methylcytosine (5mC) in many species was driven by the requirement to 
silence TEs. Potential roles in TE regulation have also been suggested for other DNA modifications, 
such as N6-methyladenine and oxidation derivatives of 5mC, although the underlying mechanistic 
relationships are poorly understood. Here, we discuss current evidence implicating DNA 
modifications and DNA modifying enzymes in TE regulation across different species. 15 
 
 
[H1] Introduction 
Organismal complexity does not correlate with genome size, which varies across species by far more than the 
number of genes it harbours, in what is known as the C-value paradox1. The main contributors to this 20 
variation are transposable elements (TEs), mobile genetic entities whose abundance in the genome differs 
immensely between species (Figure 1)2,3. TEs are considered ‘selfish’ genetic elements, whose evolution is 
primarily determined by selective pressures that only affect their own survival within the genome, with 
generally minimal effects on host phenotype. Although TE insertions can lead to adaptive effects through the 
generation of new genes or cis-regulatory elements4-6, most extant TE insertions are neutral or only mildly 25 
deleterious to the host, and have become fixed through genetic drift [G] 7. The fast evolution of the TE 
landscape is further fuelled by horizontal propagation [G] of TEs across species and viruses8. The myriad 
origins and evolutionary paths of TEs have generated thousands of distinct families that underlie remarkable 
differences in TE composition across species (Figure 1b)2,3. This diversity presents a challenge for 
categorizing TEs into groups with distinct structural and molecular properties (Figure 1a)9-11. The top of the 30 
classification hierarchy divides TEs into retrotransposons (class I TEs), which transpose via an RNA 
intermediate, and DNA transposons (class II TEs). DNA transposons are widespread and active across many 
bacterial, archaeal and eukaryotic species, but have become inactive in most mammals12,13. Retrotransposons 
can be broadly divided into long terminal repeat (LTR) and non-LTR elements, with the former being 
predominant in the TE landscape of plants, including in the relatively TE-poor genome of Arabidopsis 35 
thaliana, where several families retain the capacity for mobility14. Whereas LTR elements are also numerous 
among animal species, long interspersed nuclear elements (LINEs) are more abundant in many animal 
genomes, with nearly 20% of the mouse and human genomes being made up of LINE-1 (also known as L1) 
elements (Figure 1b)15,16. The mouse genome hosts thousands of functional LINE-1 copies with the potential 
to generate new heritable insertions in germ cells and during early embryogenesis17. In humans, a mere 80–40 
100 LINE-1 elements account for virtually all of the transposition activity observed today18, including 
retrotransposition of non-autonomous short interspersed nuclear elements (SINEs), which depend on proteins 
encoded by LINE-1 elements19. 
Although many TEs are neutral in their effect on the host, some insertions can disrupt gene function or lead 
to harmful chromosomal rearrangements, as demonstrated by over 120 disease-causing TE insertions in 45 
humans20. Additionally, exacerbated TE expression in the germline can lead to sterility in mice and fruit 
flies21,22. The resulting selective pressure has driven the evolution of numerous transcriptional and post-
transcriptional host defence mechanisms that repress TE expression (Figure 2), which have been recently 
reviewed by Molaro and Malik22. Small RNAs, including PIWI-interacting RNAs [G] (piRNAs), are the 
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primary mechanism of TE silencing in nematodes, flies and yeast, of de novo silencing in flowering plants, 
and during germ cell development in vertebrates (Figure 2a,b,d)21,23. Small RNAs can act post-
transcriptionally via targeted RNA degradation, as well as transcriptionally, inducing the deposition of 
repressive epigenetic modifications at TE loci. A key silencing pathway in mammals that exemplifies the 
rapid evolution of host defence mechanisms involve the large family of Krüppel-associated box (KRAB) 5 
zinc-finger proteins (ZFPs), which are thought to have co-evolved with TEs24,25. KRAB-ZFPs binding to TEs 
recruits KRAB-associated protein 1 (KAP1; also known as TRIM28), leading to the formation of repressive 
chromatin via multiple interacting partners (Figure 2c). ATP-dependent chromatin remodellers are also 
important players in TE regulation in both mammals and plants, providing access for methyltransferases to 
confer repressive DNA and chromatin modifications (Figure 2e)26-28. However, DNA methylation, more 10 
specifically 5-methylcytosine (5mC), is arguably the most widely adopted strategy by higher eukaryotes for 
maintaining TEs in a repressive state. Deposition of 5mC often depends on, and affects, other TE-targeting 
pathways such as those mentioned above (Figure 2). It has been argued that the need to maintain TE silencing 
drove the evolution of DNA methylation as a repressive mechanism29, and later co-opted to act in other 
contexts, such as gene imprinting. 15 
Although 5mC has been the most studied DNA modification to date, there are other modifications that have 
also been linked to TEs in different species. Apart from 5mC, the most common types of enzyme-catalysed 
DNA modifications include N4-methylcytosine (4mC) and N6-methyladenine (6mA), which are widespread 
across bacteria. Notably, 6mA is also found in varying amounts in eukaryotes30 and has recently been 
implicated in TE regulation in Drosophila melanogaster and mice31,32, although the presence and functional 20 
relevance of 6mA in higher eukaryotes remains controversial33-35. Moreover, 5mC can be oxidized by ten-
eleven translocation (TET) enzymes to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC), as part of a replication-independent pathway to DNA demethylation (Figure 3). 
Whether through their demethylating action or the direct impact of the modifications they generate, TET 
enzymes are also emerging as important regulators of TE activity36-40. 25 
Here we review the evidence implicating DNA modifications in the regulation of TE expression, focusing on 
5mC, its oxidation derivatives, and 6mA. We discuss their distribution and associated molecular mechanisms 
across species and tissues, with particular emphasis on mammalian embryogenesis, germline development 
and cancer. Modifications to RNA have also been implicated in TE regulation (Box 1) but are not 
comprehensively covered in this Review. A wider view of the effects of DNA modifications on genome 30 
function and their interplay with other aspects of gene regulation can be gained from many excellent reviews 
(For example, REFs33,41-46).  
 
[H1] 5-methylcytosine 
5mC is a widespread form of DNA methylation that is present in a large number of bacterial, archaeal and 35 
eukaryotic genomes, including fungi, plants and animals. Yet many eukaryotes lack detectable levels of 5mC, 
including D. melanogaster, Saccharomyces cerevisiae and Caenorhabditis elegans47. This suggests that 
selective pressures to adopt 5mC as a silencing mechanism have varied between different branches of 
evolution. One potential explanation for these differences is that species with large population sizes are able 
to efficiently eliminate weakly deleterious TE insertions and are therefore not dependent on DNA 40 
methylation48. 
[H2] Evidence for 5mC-mediated TE silencing across species. The distribution of 5mC across genomes is 
tied to the evolution of DNA methyltransferase (DNMT) enzymes, whose genes have undergone duplication 
and/or loss since the last common eukaryotic ancestor47. The dynamic nature of Dnmt gene evolution is 
particularly notable in the nematode lineage, where relatively closely related species display different 45 
numbers of Dnmt genes, including species where these genes are altogether absent, such as in C. elegans49. 
Interestingly, Dnmt-containing nematodes display an enrichment of 5mC at TEs, further suggesting a link 
between the emergence of 5mC and TE silencing49. Eukaryotic DNMTs are broadly classified into DNMT1 
and DNMT3 families (Figure 3). DNMT1 has a preference for hemi-methylated CpG dinucleotides, which 
enables replication-coupled maintenance of 5mC across cell division, whereas DNMT3-type enzymes mainly 50 
catalyse de novo deposition of 5mC, including in non-CpG contexts. Non-CpG methylation is particularly 
prominent in plants and is deposited by DNMT3-like enzymes (DRM1 and DRM2), as well as by members 
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of a separate chromomethylase family (CMT2 and CMT3)23. Notably, unlike other regions in the A. thaliana 
genome, TEs are heavily methylated in all cytosine contexts, consistent with a primary role of 5mC in TE 
silencing23. Indeed, A. thaliana mutants defective in DNA methylation (e.g., met1 and ddm1) display massive 
upregulation of TE expression and mobilization of certain TE families, such as copia-like LTR elements and 
CACTA DNA TEs14,50. One notable group of TEs in A. thaliana are VANDAL elements, which have evolved a 5 
mechanism to evade 5mC-mediated silencing51. Multiple VANDAL TE families encode for VANC proteins, 
which induce highly sequence-specific hypomethylation of these TEs, enabling their expression and 
propagation51. 
Other species where definitive associations between DNMT action and TE silencing have been established 
include the fungus Neurospora crassa52 and zebrafish53, which seemingly use 5mC primarily for this purpose. 10 
In mice, a role for 5mC in TE repression was first revealed in mid-gestation embryos lacking DNMT1, which 
display a marked upregulation of intracisternal A particle (IAP) endogenous retroviruses (ERVs)54. However, 
since then surprisingly little has been found about 5mC-mediated TE regulation in differentiated tissues in 
vivo. The use of Dnmt conditional knockout lines has the potential to bring deeper insights into this question, 
but analyses of these models commonly overlook the expression of TEs, or are limited to a specific family55. 15 
Nonetheless, tissue culture models have provided additional clues about the target- and tissue-specific action 
of 5mC at TEs. Namely, 5mC is largely dispensible for LINE-1 silencing in cultured embryonic fibroblasts, 
which contrasts with the pronounced effects that hypomethylation has on IAP elements27,56. However, in 
embryonic stem cells (ESCs) and neural progenitor cells, IAPs and many other ERVs are kept repressed 
through largely DNMT-independent mechanisms, and instead depend mainly on KAP1-mediated recruitment 20 
of the H3K9 methyltransferase SET domain bifurcated 1 (SETDB1)57-61. Although KAP1- and DNMT-
dependent pathways are mechanistically intertwined, they play largely complementary roles in TE silencing, 
displaying distinct preferences for different TE families59,62. 
[H2] TE regulation during epigenetic reprogramming in mice. During development, mammals undergo two 
major waves of epigenetic reprogramming where the genome is rapidly demethylated, first to form the 25 
pluripotent cells of the conceptus during pre-implantation development [G] , and second to produce gametes 
(Figure 4). In mice, DNA hypomethylation coincides with the transient upregulation of several TEs during 
both reprogramming periods63,64, including LINE-1 elements (Figure 4), although a causal link between DNA 
hypomethylation and TE expresion has not been firmly established. 
In these critical developmental stages, particularly in the germline, the risk and consequences of deleterious 30 
de novo insertions of TEs are high. To minimize the associated mutagenic risks, the host uses numerous 
complementary strategies to restrict TE mobility. In the male germline, TE expression following from 5mC 
erasure leads rapidly to the activation of the piRNA pathway (Figure 2a). piRNAs drive TE re-methylation in 
a sequence-specific manner, thus minimizing exposure of the germline to mobile elements65. Interestingly, it 
has been suggested that demethylation also drives the expression of several genes encoding proteins involved 35 
in the piRNA pathway (e.g., Mov10l1 and Mili) during reprogramming66. The importance of 5mC for TE 
repression can be observed in Dnmt3l or Miwi2 knockout mice during spermatogenesis, where LINE-1s and 
IAPs are reactivated67,68. Dnmt3l knockout mice are also phenocopied by mutants of a newly discovered 
DNMT3C enzyme that specifically methylates young TEs in mouse male germ cells69,70. The specificity of 
this enzyme highlights the selective pressure to ensure TE silencing during germ cell development, and its 40 
evolution may have been driven by high rates of retrotransposon invasion in the muroid lineage69,70. Notably, 
Dnmt3l mutation is linked to germ cell developmental arrest and infertility, which is not caused by 
retrotransposition, but via chromatin changes at active TE loci that lead to aberrant meiotic hotspot 
formation71. Similar to the male germline, oocytes make use of small RNA-based mechanisms to reduce the 
TE mutational load, with DICER-dependent endogenous small interfering RNAs (endosiRNAs [G] ) 45 
targeting MT elements in particular, and piRNAs playing an important role in IAP repression72-74. Re-
methylation of the oocyte genome occurs only after birth, providing a large window of opportunity for TE 
expression (Figure 4). Indeed, oocytes display high levels of LINE-1 expression, which is linked to fetal 
oocyte attrition75. It has been proposed that LINE-1 mediated DNA damage may provide a mechanism to 
only allow survival of oocytes with low LINE-1 expression75. 50 
A fraction of the genome is partially resistant to demethylation during epigenetic reprogramming, which 
notably includes highly mutagenic IAP elements (specifically the IAPEz family), as well as other ERV1 and 
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ERVK families76-79. In both preimplantation embryos and primordial germ cells [G] (PGCs), enrichment for 
H3K9me3 at demethylation-resistant TEs implies a role for this mark in preventing the expression of 
particularly aggressive TEs80. Indeed, depletion of SETDB1 in PGCs drives a reduction in 5mC levels at IAP 
LTRs and reactivation of these TEs80. Further insights into a potential mechanism underlying DNA 
methylation resistance to reprogramming have been gained from ESCs during culture condition-mediated 5 
transition to naïve pluripotency [G] , which recapitulates many of the key features of in vivo epigenetic 
reprogramming, including DNA demethylation81. Importantly, demethylation-resistant ERVs, including IAP 
elements, are also enriched for H3K9me3 in naïve ESCs81. It was found that this selective resistance is linked 
to the specific recruitment of UHRF1 (ubiquitin like with PHD and RING finger domains 1, also known as 
NP95) to those loci by H3K9me2/3, leading to localised maintenance of 5mC levels (Figure 2f)82-84. Thus, the 10 
resistance of a subset of TEs to DNA demethylation may be underpinned by limiting levels of UHRF1 during 
replication, which is seemingly achieved in both preimplantation embryos and PGCs by largely excluding 
UHRF1 from cell nuclei76,85. Importantly, UHRF1 is essential for maintenance of 5mC levels at IAPs in 
preimplantation embryos85. 
ESC-based models have presented many other clues about the control of TEs during early embryo and PGC 15 
development. The transition of ESCs to naïve pluripotency, their differentiation into PGC-like cells, as well 
as the conditional deletion of key enzymes, have all provided a window into the early events following DNA 
demethylation and how it affects TE control86-89. These studies have suggested that 5mC regulates many more 
TEs than can be appreciated from static knockout models, even if over time its silencing role is compensated 
by other mechanisms, such as the deposition of repressive histone marks86 or the generation of endosiRNAs89. 20 
Such insights will be useful to guide future studies into the mechanisms underlying 5mC-coupled TE control 
in vivo. 
[H2] Loss of TE 5mC in cancer. One of the hallmarks of cancer cells is global DNA hypomethylation, which 
has been proposed to promote oncogenesis90 and has been generally associated with TE reactivation91-93. In 
particular, expression of LINE-1 proteins is a common feature of multiple human cancers, which increases 25 
the risk of insertional mutagenesis driven by LINE-1-mediated retrotransposition94. High rates of somatic 
LINE-1 retrotransposition have been mostly reported in epithelial tumours (e.g., colorectal, oesophageal, 
hepatocellular, lung and ovarian cancers), whereas haematological malignancies and gliomas have little 
evidence of retrotransposition95,96. Apart from increasing retrotransposition rates, 5mC loss in cancer activates 
dormant TE-encoded promoters97. Namely, activation of an antisense promoter within LINE-1 elements 30 
commonly generates chimeric transcripts [G] with host genes, such as in the case of the MET proto-
oncogene98,99. LTR elements are also a source of oncogenic promoters, generating additional chimeric 
transcripts in various cancer types97. Treatment of cells with DNMT inhibitors (DNMTi), which are clinically 
used as therapeutic drugs in hematopoietic malignancies, leads to the emergence of numerous new TE 
chimeric transcripts that have the potential to affect cellular function100. 35 
In contrast to the developmental contexts discussed above, it would first appear that cancer cell populations 
are under no selective pressure to compensate for a loss of 5mC at TEs. Provided that TE insertions that 
compromise cancer growth are rare, tumours will easily tolerate (and may sometimes benefit from) TE 
mobility. However, a broad range of cancer types display overexpression of the ERV-repressing enzymes 
SETDB1 and LSD1, which appears to be the result of a clonal selection [G] process101,102. Depletion of either 40 
of these enzymes leads to the generation of ERV-derived double-stranded RNAs (dsRNAs), which are 
thought to activate antiviral response pathways that eventually lead to the apoptosis of cancer cells101,102. ERV 
silencing is therefore seemingly essential for cancer survival, although it remains to be established whether 
5mC loss is a driver for the clonal evolution of alternative ERV-silencing mechanisms. Interestingly, DNMTi 
treatment also leads to an interferon response that has been associated with ERV derepression103,104. 45 
Activation of TEs may therefore ironically underlie the therapeutic efficacy of DNMTi treatment, which has 
opened exciting new therapeutic avenues that look to explore the pathways that induce an antiviral response 
through ERV activation105. 
 
[H1] Oxidation derivatives of 5mC 50 
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Replicating cells can efficiently remove 5mC through a passive mechanism that involves uncoupling of the 
5mC maintenance machinery during DNA replication. However, 5mC can also be removed in an active, 
replication-independent manner, which in plants involves DNA glycosylases capable of removing the 5mC 
base directly106 (Figure 3). By contrast, active DNA methylation in vertebrates first involves conversion of 
5mC to 5hmC by an oxidation reaction (Figure 3). 5hmC was first identified in T-even bacteriophages as part 5 
of a mechanism to protect viral DNA from degradation by host restriction enzymes107, and was later found in 
a number of vertebrate tissues108. However, it was the eventual discovery that TET enzymes oxidize 5mC to 
5hmC109, as well as to 5fC and 5caC110,111, that drew widespread interest in this pathway as a mechanism for 
active DNA demethylation (Figure 3), although the generation of 5hmC also promotes replication-dependent 
demethylation112,113. Quantification of 5hmC levels in mice, amphibians and zebrafish have demonstrated that 10 
5hmC abundance is highly variable among different tissues, and that strong enrichment of 5hmC in the 
central nervous system is conserved between species114-116. Although it is tempting to suggest a link between 
5hmC abundance in the brain and the high activity of LINE-1 observed therein (Figure 4)117, this remains to 
be tested. High levels of 5hmC are also found in ESCs and dramatically decrease upon differentiation118. 
Furthermore, 5hmC levels are inversely correlated with cell proliferation and are substantially lower in cancer 15 
cells compared to healthy tissues (Figure 4)119. Less is known about the distribution of 5caC and 5fC, which 
are 10–100 times less abundant than 5hmC. For example, in mouse ESCs 5hmC levels are around 0.4% of all 
cytosines (~10% of all 5mC) and only ~1% of those bases are further converted to 5fC/5caC, although there 
is substantial inter-tissue variation110,120. 
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[H2] TETs as regulators of mammalian TE expression. TET enzymes emerged from a common metazoan 
ancestor and are part of the larger TET–JBP (J-binding protein) family that is also represented in several 
other species, including basidiomycete fungi121. Interestingly, some TET–JBP genes in fungi are encoded 
within KDZ (Kyakuja, Dileera and Zisupton) DNA transposons, which may have contributed to gene 
duplication and/or play a role in protein function122. These TET–JBP genes oxidize 5mC at repetitive 25 
elements, including Ty–gypsy-like TEs and, remarkably, the KDZ elements themselves123. Surprisingly, Ty3–
gypsy retrotransposons were also found marked by 5hmC in rice cultivars, despite the absence of a known 
TET–JBP protein in plants124. 
In mammalian cells, TET enzymes bind cis-regulatory regions, such as gene promoters and enhancers, where 
their action implicates TETs in cell differentiation, neuronal function and oncogenesis45. However, 30 
accumulated evidence suggests that TET proteins also work as regulators of mammalian TE expression. 
Early profiling efforts in mouse ESCs showed that 5hmC is enriched at the 5′ untranslated region (UTR) of 
LINE-1 elements, and suggested that these TEs underwent TET-dependent removal of 5mC125,126. This 
potentially implicated TET enzymes in the demethylation of TEs during mouse preimplantation development. 
Notably, in zygotes [G] 5hmC occurs asymmetrically with respect to the two parental genomes in a mirror 35 
image to concomitant 5mC placement. Shortly after fertilization, the paternal genome undergoes rapid global 
loss of 5mC and gain of 5hmC, 5fC and 5caC, whereas 5mC levels on the maternal genome are largely 
maintained during the same period, and no accumulation of 5hmC is observed127-129. However, whereas 5hmC 
deposition on the paternal genome is dependent on oocyte-derived TET3, global loss of 5mC does not require 
its activity128,129. The demethylating role of TET3 appears to instead be restricted to a few genomic regions. 40 
Notably, TET3 depletion leads to an increase in 5mC levels at LINEs, SINEs and DNA transposons in the 
paternal pronucleus128, whereas its action is less prominent at LTRs, especially in ERV1 and IAP classes130. 
This pattern coincides with the known preferred targets of demethylation in the zygote77,131, which are 
associated with differences in H3K9me2/3 deposition, as discussed above. Despite the preferential activity of 
TET3 on the paternal pronucleus, TET3 also facilitates maternal DNA demethylation at repetitive regions, 45 
albeit to a lesser extent130. 
The above observations suggest that TET3-dependent demethylation underlies TE activation during 
epigenetic reprogramming. However, TET3 is dispensable for the activation of TEs (e.g., LINE-1, IAP, 
ERV1 and ERVL elements) in preimplantation embryos, irrespective of their dependency on this enzyme for 
demethylation132. Whereas simultaneous deletion of Tet1 and Tet3 is associated with a decrease in IAP 50 
expression in blastocysts, LINE-1 elements remain unaffected, despite visible increases in 5mC levels36. 
Similar observations have been made in ESCs, where depletion of the main TET enzymes expressed therein 
(TET1 and TET2) drives an increase in 5mC levels at evolutionarily young LINE-1 elements but does not 
lead to their silencing37, despite the fact that these elements are relatively well expressed in ESCs when 
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compared with differentiated cells. These findings suggest that additional 5mC-independent mechanisms can 
couteract the effects of 5mC alterations at LINE-1 elements. Notably, TET enzymes can also serve as 
transcriptional co-activators or co-repressors in a catalytic-independent manner through interactions with 
transcriptional regulators, such as O-glcNAC transferase (OGT)133-135, the SIN3A complex136, and Polycomb 
repressive complex 2 (PRC2)137 (Figure 5). Interestingly, TET1 recruits the SIN3A co-repressor complex to 5 
LINE-1 elements in ESCs, thus directly coupling active DNA demethylation to a repressive mechanism that 
ensures LINE-1 silencing37. Another candidate group of repressors that may counteract TET1 action at LINE-
1s are methyl-CpG binding domain (MBD) proteins38. MERVL repression is also controlled by TET2-
dependent recuitment of histone deacetylases (HDACs) and, remarkably, by oxidation of RNA 5mC (Figure 
5; Box 1)138.  10 
 
Given that TET enzymes are expressed during epigenetic reprogramming, are specific mechanisms required 
to prevent active demethylation of highly mutagenic TEs, such as IAPs? One hypothesis is that the KAP1–
SETDB1 pathway of H3K9me3 deposition protects certain TEs from TET activity. Consistent with this 
model, KAP1 binding and 5hmC deposition at LINE-1s appears to be mutually exclusive in both mouse and 15 
human ESCs, where 5hmC is enriched at evolutionarily young subfamilies, and KAP1 binds older 
elements37,62. However, SETDB1 depletion in mouse ESCs leads only to a subtle increase in 5hmC levels 
(and concomitant decrease in 5mC) at demethylation-resistant TEs, including IAPs139. Although the absence 
of SETDB1 enables TET2 to activate IAP expression in a catalytic-dependent manner, this appears to be the 
result of indirect effects39. These findings argue against a major role for H3K9me3 in protecting IAPs from 20 
TET-mediated demethylation. It is unclear whether other mechanisms minimize the activity and impact of 
TETs on reprogramming-resistant loci, and to what extent the findings in ESCs reflect the more dynamic in 
vivo state.  
 
[H2] A direct role for 5hmC, 5fC or 5caC in TE regulation? Although oxidized forms of 5mC are normally 25 
considered simple intermediates of DNA demethylation, at least 5hmC and 5fC are predominantly stable in 
vivo and may play direct roles in transcriptional regulation140,141. One important consideration is whether the 
levels of each of these modifications are high enough to effect functional and phenotypic outcomes. 
Nevertheless, a localized accumulation of oxidized forms of 5mC could affect the accessibility of DNA-
binding proteins by changing the physical properties of DNA. For instance, binding of the transcription 30 
factors Wilms tumour 1 (WT1) and early growth response protein 1 (EGR1) is impaired or even abolished by 
the presence of oxidized derivatives of 5mC (Figure 5)142. Furthermore, 5fC and 5caC impede transcription 
by binding to RNA polymerase II (Pol II), inducing Pol II pausing and delaying transcriptional elongation143, 
although it remains unclear to what extent this impacts gene expression in vivo. Oxidized 5mC bases can also 
be recognized by specific ‘readers’ that subsequently direct chromatin organization and remodelling (Figure 35 
5). DNA glycosylases (MPG and NEIL3), helicases (RECQ1) and the SALL4A transcription factor are 
among the 5hmC-specific readers, while 5fC and 5caC recruit a large number of DNA repair proteins, TP53, 
chromatin remodelling factors, and forkhead box transcription factors144-146. Despite the enticing enrichment 
of oxidized forms of 5mC at specific TE classes, it remains to be seen whether any of these mechanisms are 
involved in their transcriptional regulation. 40 
 
[H1] N6-methyladenine 
6mA is present across all kingdoms of life30 and has recently received renewed attention due to a number of 
quantification, characterization and profiling efforts in several eukaryotic species, including mice and 
humans31,32,147-150. With 6mA levels varying widely across species (Figure 6), sensitive assays have been 45 
required to allow the detection of extremely low levels of this modification. The presence of such low 6mA 
levels has not only been questioned from a technical perspective34,35, but also triggered a discussion about the 
potential functional importance of 6mA in these cases. Nevertheless, a number of different roles have been 
suggested for 6mA, with TE regulation being a recurrent theme across several species. 
In bacteria, 6mA plays a key role as part of antiviral restriction-modification systems, but it has also been 50 
implicated in other processes, including transcriptional regulation151. Interestingly, 6mA regulates the Tn10 
DNA transposon, whose activity is dramatically increased in Escherichia coli strains mutant for the 6mA 
methyltransferase dam152. Several unicellular eukaryotes have also long been known to contain high levels of 
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6mA, including Tetrahymena thermophila and Chlamydomonas reinhardtii, wherein 6mA exists within an 
ApT-containing motif and is thought to play a role in nucleosome positioning at transcription start sites147,153. 
Species lacking an ApT motif at 6mA sites generally contain lower levels of this modification, and diverge 
with respect to its genomic distribution and putative roles (Figure 6). The evolution of different 6mA 
methyltransferases and demethylases (Figure 3) may have therefore conferred species-specific roles to this 5 
DNA modification. Notably, two plant pathogens (Phytophthora infestans and Phytophthora sojae) display 
an enrichment of 6mA at TEs and low-expressing genes, suggesting that it plays a role in TE silencing154. A. 
thaliana also displays 6mA enrichment at TEs, but in this case the mark correlates with host gene 
activation155. Determining whether 6mA plays a functional role in either or both of these contexts will be the 
first step to understanding how this apparent duality is achieved.  10 
 
[H2] TEs and 6mA in metazoans. The levels of 6mA in metazoans are substantially lower than those seen in 
species such as E. coli and T. thermophila (Figure 6), thus placing a premium on having both sensitive and 
accurate detection systems for sequencing and biochemical detection methodologies33. This is an ongoing 
technical challenge, as a recent ultrasensitive mass spectrometry approach could not confirm the presence of 15 
6mA in mouse ESCs34. Genome-wide mapping of 6mA using antibody-based enrichment techniques is also 
particularly prone to artefacts due to the high background resulting from the affinity of immunoglobulin G 
(IgG) for simple repeats35.  
 
With these caveats in mind, the identification and manipulation of 6mA methyltransferases and/or 20 
demethylases in some species have nonetheless provided clues to the putative roles of 6mA therein. In C. 
elegans, deletion of N6-methyl adenine demethylase 1 (nmad-1) leads to exacerbation of a 
transgenerationally-coupled infertility phenotype seen in spr-5 (a H3K4me2 demethylase) mutants, although 
the underying mechanisms are unclear148. Interestingly, D. melanogaster contains a TET orthologue [G] that 
acts as a DNA 6mA demethylase (thus renamed DMAD), the deletion of which leads to a clear derepression 25 
of TEs31. DMAD is essential for D. melanogaster embryonic development and promotes germ cell 
differentiation31. Accordingly, levels of 6mA are developmentally regulated, with early embryonic stages 
displaying a 6mA content of ~0.07% of all adenines, which then declines to 0.001% in later stages, and a 
similar pattern is seen during early germ cell development. In ovaries, 6mA is found enriched at multiple TE 
families and this is more pronounced in DMAD mutants, where TE activation was observed. TE families that 30 
were both 6mA enriched and derepressed in DMAD mutants included LTR (Idefix, Copia) and non-LTR 
(Het-A, Tart) TEs31. Although it is tempting to implicate 6mA in fruitfly TE activation, further experiments 
will be needed to demonstrate that the action of DMAD at TEs is both direct and dependent on its catalytic 
activity.  
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A potential role of 6mA during development has also been suggested in pigs and zebrafish where, similar to 
D. melanogaster, high levels of 6mA have been reported during preimplantation stages of embryogenesis 
(with 6mA content peaking at 0.1–0.2% of all adenines)156. In zebrafish this is coupled to an enrichment of 
6mA at repetitive elements, including LINE-1, LTR and DNA TEs156. 6mA has also been associated with TE 
regulation in the mouse, where knockout of the 6mA demethylase Alkbh1 in ESCs leads to the accumulation 40 
of 6mA at evolutionarily young LINE-1 elements, concomitant with their silencing32. Similarly, 6mA levels 
at LINE-1s are raised in the prefrontal cortex of mice subjected to chronic stress, and this is correlated with 
LINE-1 silencing157. These findings contrast with those in fruitflies — particularly that 6mA is associated 
with TE repression in mice but TE activation in D. melanogaster — highlighting key differences in the 
associated mechansims across species, which remain unclear. Human lymphoblastoid cells have also been 45 
reported to display an enrichment of 6mA at the 5′ UTR of young LINE-1 elements158, suggesting a 
potentially conserved function of this modification between mice and humans. Interestingly, cancer types that 
have been associated with high levels of LINE-1 retrotransposition, such as gastric and liver cancers, undergo 
6mA loss150. Conversely, 6mA is markedly upregulated in glioblastoma159, where LINE-1 activity has not 
been detected, raising the possibility that 6mA levels are linked to LINE-1 regulation in cancer. It will 50 
therefore be important to establish whether functional links between 6mA and TE deregulation exist in cancer 
that could drive LINE-1 mobility therein. 
 
[H2] Relationship between 6mA and 5mC. Most species have one predominant form of DNA methylation 
(Figure 6), with this mutual exclusivity being particularly notable amongst early diverging fungi33,160. In the 55 
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special case of C. reinhardtii, which contains relatively high levels of both 5mC and 6mA, there is an 
interesting spatial compartmentalization between the two marks, with 5mC covering TEs and gene bodies, 
and 6mA marking the transcription start sites of active genes147. Given these observations, could 6mA have 
emerged in species that lack 5mC to provide the host genome with a comparable TE silencing tool? This 
could be the case for Phytophthora species, for example, although a functional role for 6mA in TE silencing 5 
has not been formally tested therein. However, the diversity in the distribution and apparent roles of 6mA 
across different species argue against such a simplistic model. For example, in T. thermophila 6mA is 
associated with the promoters of active genes153, and in D. melanogaster increasing levels of 6mA correlate 
with TE activation31. In vertebrate genomes, given the high abundance of 5mC, it may seem unlikely that the 
putative silencing capabilities of 6mA have been harnessed to complement the action of 5mC. However, it 10 
has been proposed that during developmental epigenetic reprogramming in vertebrates, 6mA could 
compensate for the loss of 5mC and contribute to the maintenance of TE silencing and/or transcriptional 
regulation of genes46. Indeed, it is striking that the peak of 6mA deposition during preimplantation 
development of pigs and zebrafish coincides with a period of 5mC hypomethylation156. In this respect, it is 
also interesting to note that 6mA reportedly targets mainly young, highly active LINE-1s in mouse ESCs32, 15 
which are the same subfamilies that undergo TET-mediated 5mC demethylation in these cells37. Thus, it is 
possible that 5mC and 6mA bear mechanistic links during epigenetic reprogramming that ensure an anti-
correlation between the two marks. However, in Alkbh1 knockout ESCs, increasing 6mA levels at LINE-1 
elements are associated with a concomitant increase in 5mC32, which does not support the hypothesis. It 
remains to be seen whether this relationship differs during epigenetic reprogramming. 20 
 
[H1] Conclusions and perspectives 
Advances in genomics and epigenomics have brought in a new era in the study of TE regulation and its 
impact on host genomes. This includes investigating the roles of an expanding repertoire of DNA 
modifications that are potentially far more widespread across species than previously thought. Using the 25 
regulatory signals provided by DNA modifications to control TEs seems to have been a commonly adopted 
strategy throughout evolution, albeit displaying intriguingly high variation across even closely related 
species. Comparative genomics and epigenomics efforts will continue to provide clues into the intricate 
relationships between TE evolution and that of DNA modifying enzymes. However, are DNA modifications 
themselves instructive for TE regulation? Can we uncouple the role of DNA modifying enzymes from that of 30 
the DNA modifications? Although the case for 5mC appears robust, it is also clear that 5mC-mediated TE 
silencing is context dependent. For other modifications the picture is far less clear, namely because in many 
genomes the levels of these modifications are so much lower than those of 5mC. Additionally, manipulating 
the expression of DNA modifying enzymes may lead to indirect effects on TEs, as we found recently for IAP 
regulation by TET239. Known non-catalytic functions of DNMTs and TETs can also confound results and are 35 
rarely tested for. These considerations seem particularly relevant for the more recently described 6mA-
modifying enzymes, whose effects on TEs may be unrelated to their ability to modulate 6mA levels. The 
advent of epigenetic editing tools offers the opportunity to tackle these questions by altering the levels of 
DNA modifications at specific loci while also controlling for catalytic effects161. 
It is now clear that the impact of TEs on genomes is dictated to a large extent by the regulatory activities that 40 
target them, including the action of DNA modifying enzymes. Dissecting the mechanisms underlying TE 
regulation is therefore pivotal to understanding how TEs contribute to genome evolution, development and 
disease. Encouragingly, our increased understanding of TE regulation will enable the exploration of novel 
therapeutic avenues for cancer that, for example, aim to activate an ERV-mediated antiviral response. As the 
role of modifications other than 5mC are further uncovered, the opportunities to explore these mechanisms 45 
for technological and clinical benefit will increase. 
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Box 1 | The other nucleic acids: impact of RNA modifications on TE expression. 
To date more than 100 types of chemical modifications in RNA have been characterized, which are present in 
almost all types of RNA including mRNA, tRNA, rRNA, long non-coding RNA (lncRNA) and small nuclear 
RNA (snRNA)162. There is mounting evidence that functional roles of RNA modifications are as complex as 
those of DNA and chromatin, including associations with transposable element (TE) regulation. 5 
 
[b1] N6-methyladenine 
N6-methyladenine (6mA; commonly termed m6A when in RNA) is the most abundant modification known 
on mRNA and lncRNA, and has been implicated in various aspects of mRNA metabolism including nuclear 
export, RNA structure, RNA stability and mRNA translation163. In Arabidopsis thaliana TE transcripts 10 
display relatively high abundance of 6mA, which appear to be linked to the maintenance of low levels of TE 
expression164. Using computational methods to map non-unique reads to specific TE classes, Zhang et al 
demonstrated that Alu elements are significantly enriched for 6mA165, which may be involved in regulating 
Alu RNA conformation166. Circular RNAs (circRNAs), which form a covalently closed continuous loop, are 
also enriched with 6mA modifications167. Interestingly, TEs are significantly enriched in the flanking regions 15 
of 6mA-enriched circRNAs in both human embyonic stem cells and HeLa cells, suggesting that TE density 
may be associated with 6mA deposition in circRNAs167. 
 
[b1] Ribose methylation 
2′-O-methylated nucleosides, which protect RNA from degradation, are found in all major classes of 20 
eukaryotic RNA and are the most abundant modifications of rRNA162. PIWI-interacting RNAs (piRNAs), 
which are master regulators of TEs in the germline, also undergo 2′-O-methylation by the HEN1 
methyltransferase168,169. In the germline of Drosophila melanogaster and zebrafish, loss of HEN1 results in 
decreased piRNA levels and mild derepression of TEs, showing that piRNA methylation is crucial for its 
stabilization and transposon silencing168,170. 25 
 
[b1] Wobble uridine modifications in tRNA 
The wobble uridine residues of tRNAs (U34) are generally modified in all species171. Mutant forms of 
Elongator complex, which is involved in U34 modifications, lead to substantial downregulation of Ty1 
retrotransposons and a small number of genes in the proximity of Ty elements in budding yeast131. However, 30 
overexpression of its target tRNAs does not rescue the effect of the mutation on expression of nearby genes, 
suggesting the involvement of tRNA modifications other than wobble nucleotide modifications132. 
 
[b1] 5mC and 5hmC 
5-methylcytosine (5mC; commonly termed m5C when in RNA) is highly abundant in tRNA and rRNAs and 35 
is catalysed by DNMT2 and NSUN proteins163. In D. melanogaster and Dictyolstelium discoideum, DNMT2 
was shown to have a role in TE regulation172,173. Although this effect was attributed to DNA methylation 
rather than RNA methylation, others did not reproduce these observations174. Instead, a recent study 
suggested that the TE activation seen in D. melanogaster Dnmt2 and Nsun2 mutants is related to reduced 
tRNA stability, indicating a potential link between tRNA modifiers and TE regulation175. A role in TE 40 
regulation has also been proposed for TET-mediated oxidation of RNA 5mC into 5-hydroxymethylcytosine 
(5hmC)138. In mouse embryonic stem cells, TET2 does not modify MERVL DNA but it does increase 5hmC 
levels at MERVL transcripts, which correlates with their destablilization138. 
 
 45 
 
Figure legends 
 
Figure 1 | Transposable element classification and species distribution. a | Transposable 
elements (TEs) are classified into retrotransposons (class I), which are defined by their use of a reverse 50 
transcribed RNA intermediate, and DNA transposons (class II). TEs can be further subdivided into orders 
(e.g., long terminal repeat (LTR), long interspersed nuclear element (LINE) and short interspersed nuclear 
element (SINE)) and superfamilies (e.g., endogenous retrovirus (ERV), Copia and LINE-1), following the 
classification system proposed by Wicker et al9. The TE order is defined based on key differences in the 
transposition mechanism. For example, LTRs use an integrase to insert TE cDNA into the genome, whereas 55 
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LINE elements use an endonuclease to perform target-primed reverse transcription at the insertion locus. 
b | The genomic abundance and composition of TEs (pie charts; annotation from RepeatMasker) varies 
widely across species. This is also reflected in the extent and diversity of TE activity, for which examples of 
transposition-competent families are provided. For example, LINEs and SINEs are highly abundant in human 
and mouse, where they are also the main active TE orders, despite a large fraction of the genome also 5 
containing LTR and DNA transposons. By contrast, DNA transposons are the main TE class in 
Caenorhabditis elegans, where they remain active. A. thaliana, Arabidopsis thaliana; APE, apurinic 
endonuclease; ATP, packaging ATPase; C-INT, c-integrase; CYP, cysteine protease; D. melanogaster, 
Drosophila melanogaster; DIRS, Dictyostelium intermediate repeat sequence; EN, endonuclease; EVD, 
Evadé; H. sapiens, Homo sapiens; HEL, helicase; IAP, intracisternal A particle; ITR, inverted terminal 10 
repeat; M. musculus, Mus musculus; MLV, murine leukaemia virus; ORF, open reading frame; POL B, DNA 
polymerase B; REP, replication initiator protein; RH, RNase H; RT, reverse transcriptase; RTE, 
retrotransposabe element; SVA, an element formed of fragments of SINEs, variable number tandem repeats 
(VNTRs) and Alu elements; TIR, terminal inverted repeat; TPase, transposase; TR, terminal repeat (variable 
structure); YR, tyrosine recombinase. 15 
 
 
Figure 2 | Interplay between key transposon silencing mechanisms and DNA 
methylation. a | In the animal germline, transposable element (TE) mRNAs are cleaved to PIWI-
interacting RNAs (piRNAs) by MILI and MIWI in mouse, PIWI and Aubergine (AUB) in Drosophila 20 
melanogaster and PRG1 in Caenorhabditis elegans, followed by post-transcriptional gene silencing [G] 
(PTGS). Transcriptional gene silencing [G] (TGS) of TEs via epigenetic modifications is achieved by 
piRNA-loaded MIWI2 (mouse) conferring de novo 5-methylcytosine (5mC)65,68, and piRNA-loaded PIWI in 
D. melanogaster (WAGO and CSR1 in C. elegans), resulting in H3K9me2/3 enrichment (reviewed in 
REF21). b | In flowering plants, RNA-dependent DNA methylation [G] (RdDM) begins by RDR6 making 25 
transcribed TE RNAs double stranded, followed by DCL2- and DCL4-mediated cleavage to 21–22-
nucleotide small RNAs (sRNAs). DRM1 and DRM2 generate 5mC at TE loci, resulting in silencing23. RdDM 
is accompanied by PTGS mediated by Argonaute 1 (AGO1) and AGO2 loaded with sRNAs. In rice and 
Arabidopsis thaliana germlines, DEMETER family glycosylases remove DNA methylation from TEs in 
gamete companion cells176 leading to TE expression. At least in pollen, this leads to RdDM-mediated TE 30 
silencing in the adjacent sperm cell176 c | In early embryogenesis, Krüppel-associated box (KRAB) proteins 
containing zinc fingers (ZNFs) recognize TEs in a sequence-specific manner25, recruiting the KAP1 (also 
known as TRIM28) cofactor. KAP1 provides a scaffold for the SET domain bifurcated 1 (SETDB1) H3K9 
methyltransferase and heterochromatin protein 1 (HP1), forming a repressive chromatin structure 58,60, 
followed by de novo DNA methylation177. d | TE DNA methylation in plants is reinforced by RdDM, 35 
similarly to part b, except that RNA polymerase IV (POL IV) and POL V can transcribe methylated DNA. 
POL IV transcripts are processed to 24-nucleotide sRNAs by RDR2 and DCL3 and are loaded onto AGO4 
and AGO6. POL V TE transcription provides a scaffold for AGO4 and AGO6 binding, which then recruits 
DRM1 and DRM2, leading to DNA methylation in all sequence contexts23. e | Asymmetric DNA methylation 
is maintained by chromomethylase 2 (CMT2), and at heterochromatin, DDM1 remodels chromatin to allow 40 
methyltransferase access28 f | TE methylation in mammals is maintained following replication by DNA 
methyltransferase 1 (DNMT1) and UHRF1 action on hemimethylated DNA. During reprogramming, 
H3K9me3-enriched intracisternal A particles (IAPs) and long interspersed nuclear element 1 (LINE-1) 
elements are protected from passive demethylation, probably by UHRF1 recruitment84. 
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Figure 3 | DNA modifications and DNA modifying enzymes. Chemical structure of unmodified 
and modified DNA bases and their respective DNA modifiers in different species. See also Figure 6 for the 
levels of 5-methylcytosine (5mC) and N6-methyladenine (6mA) in different species, which are associated 
with the evolution of DNA modifying enzymes. Cytosine is methylated by DNA methyltransferase (DNMT) 
enzymes, which fall into different major families (shown are DNMT1, DNMT3 and chromomethylase (CMT) 50 
families) 47. In Arabidopsis thaliana, 5mC can be directly removed by glycosylases, followed by repair via 
the base excision repair (BER) pathway106. In metazoans, 5mC can be oxidized into 5-hydroxymethylcytosine 
(5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) via the TET–JBP family of enzymes109-111. 
Thymine DNA glycosylase (TDG) can remove 5fC and 5caC bases, triggering base excision repair (BER). 
All modified cytosine bases can also be removed passively through replication-coupled demethylation112,113. 55 
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6mA methyltransferases (MT) and demethylases (DM) have started to be identified in higher 
eukaryotes31,32,150. C. elegans, Caenorhabditis elegans; DME/ROS1, DEMETER and REPRESSOR OF 
SILENCING 1 family of 5mC DNA glycosylases; D. melanogaster, Drosophila melanogaster; H. sapiens, 
Homo sapiens; M. musculus, Mus musculus.  
 5 
Figure 4 | Dynamics of 5mC, 5hmC and LINE-1 expression during mouse development. 
During mouse development, the genome undergoes two waves of epigenetic reprogramming, leading to rapid 
loss of 5-methylcytosine (5mC) during primordial germ cell (PGC) migration, and immediately following 
fertilization. During these periods, class-dependent DNA methylation is observed at transposable elements 
(TEs): whereas long interspersed nuclear element 1 (LINE-1) elements undergo a complete erasure of 5mC, 10 
certain endogenous retroviruses (ERVs) such as intracisternal A particles (IAPs) are resistant to DNA 
demethylation63,64. After PGC reprogramming, the establishment of DNA methylation takes place at different 
times in males and females: in male PGCs, methylation initiates in prospermatogonia, whereas re-methylation 
of the oocyte genome only occurs after birth, opening a window of opportunity for TE activation. Indeed, 
LINE-1s and mammalian apparent LTR retrotransposons (MaLRs) are activated in mouse oocytes75. The 15 
second wave of 5mC loss, during preimplantation, coincides with transient accumulation of 5-
hydroxymethylcytosine (5hmC) levels and is characterized by high TE expression levels, including LINE-1. 
High 5hmC levels are also observed in the brain, where LINE-1s are also expressed117, but most other 
somatic tissues are largely depleted for 5hmC and LINE-1 activity. Finally, in cancer cells, global DNA 
hypomethylation is a ubiquitous feature and 5mC loss at TEs is highly correlated with their activation in 20 
cancer91-93. 
 
Figure 5 | Potential mechanisms for TET-mediated regulation of TEs. Biochemical studies and 
cell culture experiments (mainly on embryonic stem cells) have revealed different modes by which TET 
proteins can regulate transcription, thus potentially affecting transposable element (TE) expression. The top 25 
half of the figure refers to mechanisms with documented examples in the regulation of TE expression, 
whereas the bottom half presents mechanisms known to act at other loci but with no reported role in TE 
regulation. First and foremost, TETs are thought of as DNA demethylases, and have been shown to decrease 
5-methylcytosine (5mC) levels at long interspersed nuclear element 1 (LINE-1) elements, intracisternal A 
particles (IAPs), short interspersed nuclear elements (SINEs) and DNA transposons36-38,128. TETs can also 30 
modify RNA and destabilize TE transcripts such as murine endogenous retrovirus L (MERVL)138. 
Additionally, TET proteins play non-catalytic roles in TE regulation through the recruitment of repressor 
complexes such as SIN3A, MBD and HDAC37,38 138, as well as potential co-activators such as OGT37. The 
modifications generated by TETs (5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC)) can themselves affect downstream pathways, by either preventing binding of 35 
particular proteins, such as transcription factors (TFs)142, or by recruiting modification-specific readers144-146 
— it is unknown whether these mechanisms act at TEs.  
 
Figure 6 | Variation in 6mA abundance and relationship with TEs across species. Levels of 
N6-methyladenine (6mA) vary widely across species and also show spatial and temporal differences, such as 40 
between the micronucleus (MIC) and macronucleus (MAC) of Tetrahymena thermophila, and the vegetative 
and reproductive phases of Arabidopsis thaliana development. Generally, high levels of 6mA correlate with 
low levels of 5mC and are associated with a palindromic ApT motif that enables replication-coupled 
maintenance of the modification. Documented relationships with transposable elements (TE) are described, 
including the enrichment of 6mA at TEs, or more direct evidence involving the manipulation of 6mA-45 
modifying enzymes, as in the case of Escherichia coli, Drosophila melanogaster and mouse (Mus musculus). 
For some species a potential role in TE regulation has not been formally investigated. C. anguillulae, 
Catenaria anguillulae; C. elegans, Caenorhabditis elegans; C. reinhardtii, Chlamydomonas reinhardtii; 
D. rerio, Danio rerio; H. sapiens, Homo sapiens; H. vesiculosa, Hesseltinella vesiculosa; P. infestans, 
Phytophthora infestans; X. laevis, Xenopus laevis. 50 
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Genetic drift 
Changes in the frequency of a given allele in a population due to random sampling. Genetic drift can lead to the fixation 
of a particular allelic variant in a population without any selective pressure. 
 
Horizontal propagation 5 
Better known as horizontal gene transfer, it entails the transfer of genetic material between organisms. It contrasts with 
vertical transfer, which occurs from parents to offspring via the germline.  
 
PIWI-interacting RNAs 
(piRNAs). A class of 26–30-nucleotide small, single-stranded RNAs that interact with the PIWI family of proteins. 10 
 
Pre-implantation development 
The first phase of embryonic development that begins after fertilization and ends upon implantation of the blastocyst 
into the uterus. 
 15 
endosiRNAs 
Small RNAs (20–23 nucleotides) generated from double-stranded RNAs, including sense–antisense transcript hybrids. 
 
Primordial germ cells 
(PGCs). The precursor cells of mammalian gametes that are specified at around embryonic day 6.25 in mice, and that 20 
differentiate into oocytes or sperm. 
 
Naïve pluripotency 
A stem cell state that resembles that of the inner cell mass of the blastocyst.  
 25 
Chimeric transcripts 
In the context of this Review, chimeric transcripts are RNA molecules that involve a fusion between a transposable 
element acting as a transcriptional promoter and a host gene. 
 
Clonal selection 30 
In the context of cancer evolution, clonal selection entails the selective expansion of a particular cell due to genetic 
and/or epigenetic changes that confer a growth advantage. 
 
Zygotes 
One-cell embryos resulting from the fusion of sperm with an oocyte, i.e., fertilization. 35 
 
Orthologue 
Orthologues are genes from different species that have evolved from a common ancestor. 
 
Post-transcriptional gene silencing 40 
(PTGS). The process of silencing a gene after it has been transcribed, e.g., by cleavage of its nascent RNA. 
 
Transcriptional gene silencing 
(TGS). Silencing a gene at the transcriptional level, i.e., by preventing the transcriptional process, often by epigenetic 
modification of the locus to a less open conformation, disfavouring binding of RNA Pol II. 45 
 
RNA-dependent DNA methylation 
(RdDM). One of the key strategies for de novo and maintenance DNA methylation in Arabidopsis thaliana, whereby 
RNA molecules from expressed loci direct DNA methylation in a sequence-dependent manner. 
 50 
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mechanisms regulating TEs. Beyond roles for 5-methylcytosine (5mC), they discuss TET-
mediated oxidation products of 5mC, as well as ongoing debates about the functional 
relevance of adenine methylation. 
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While the labyrinth is developing, it is supported
structurally by the SPONGIOTROPHOBLAST, which forms a
compact layer of non-syncytial cells between the
labyrinth and the outer giant cells. In the absence of
direct lineage analysis, it has been assumed, from his-
tological studies and from the continuity of marker
gene expression, that the spongiotrophoblast largely
derives from the cells of the ectoplacental cone. The
maternal blood supply passes through the spongiotro-
phoblast via large central ‘arterial’sinuses in which the
maternal endothelial cells are eroded away and
replaced by trophoblast cells. The maternal blood
eventually enters into the tortuous, small spaces of the
labyrinth where it bathes directly the fetal trophoblas-
tic villi, ensuring the ease of material exchange
between the two blood systems (FIG. 2). The fetal vascu-
lature of the placenta is connected to the developing
fetus by the umbilical artery and vein.
The placenta undertakes many functions beyond
the simple exchange of materials between the mater-
nal and fetal environments. For example, the tro-
phoblast giant and spongiotrophoblast cells produce
many specialized products, including hormones (such
as placental lactogens6), angiogenic factors (such as
proliferin7and vascular endothelial growth factor
(VEGF)8,9) and tissue remodelling factors (such as
matrix metalloproteinases (MMPs)10 and urokinase-
type plasminogen activator (uPA)11). The mouse pla-
centa is, therefore, a highly specialized unit that is sup-
ported by other cells involved in both its structure and
function in fetal–maternal exchange.
Signalling in early trophoblast development
Early experiments in mice showed that the trophoblast
depends on signals from the ICM and its later deriva-
tives for its proliferation and differentiation. As men-
tioned earlier, trophectoderm cells away from the ICM
at the blastocyst stage fail to proliferate and form tro-
phoblast giant cells, a terminally differentiated cell
type. If, however, a new ICM is inserted into an empty
trophectodermal vesicle, a new proliferative centre is
Mouse placental development
The trophoblast layer of the placenta arises from the first
cell type to differentiate in the mammalian embryo —
the outer TROPHECTODERM layer of the BLASTOCYST (FIG. 1).
Lineage analysis in the mouse embryo has shown that,
by embryonic day (E) 3.5 of development, two distinct
cell lineages are formed: the outer, specialized trophecto-
dermal epithelium, which pumps fluid internally to
form the blastocoelic cavity, and the INNER CELL MASS
(ICM), which lies to one side of the cavity. By E4.5,
around the time of IMPLANTATION, the formation of differ-
ent trophoblast cell types is underway. The trophecto-
derm cells overlying the ICM continue to proliferate and
give rise to the diploid EXTRA-EMBRYONIC ECTODERM and ECTO-
PLACENTAL CONE of the early postimplantation conceptus5
(FIG.1).The trophectoderm cells away from the ICM stop
dividing but continue to ENDOREDUPLICATE their DNA to
form TROPHOBLAST GIANT CELLS. In the postimplantation
embryo, more giant cells form from the outer regions of
the ectoplacental cone and surround the entire concep-
tus.As development proceeds, the extra-embryonic ecto-
derm expands to form the CHORIONIC epithelium,which is
lined by a thin layer of mesothelial cells. The ALLANTOIS
arises from the mesoderm at the posterior end of the
embryo and makes contact with the chorion at around
E8.5. This event is termed chorioallantoic fusion,
although no actual cell fusion takes place.After hours of
allantoic attachment, folds appear in the chorion that
mark the sites where feto-placental blood vessels grow in
from the allantois to generate the fetal components of
the placental vascular network. The trophoblast, with its
associated fetal blood vessels,undergoes extensive villous
branching to create a densely packed structure called the
LABYRINTH. Coincident with the onset of morphogenetic
branching, chorionic trophoblast cells begin to differen-
tiate into the various layers of LABYRINTHINE TROPHOBLAST
cells. In mice, there are two layers of SYNCYTIOTROPHOBLAST
cells (FIG. 2) that are in direct apposition to the endothe-
lial cells of the fetal-derived blood vessels.An additional
mononuclear cell type of unknown origin and function
remains outside the syncytiotrophoblast layer.
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Figure 1 | Placental development in the mouse. Early development of the mouse embryo from embryonic day (E) 3.5–E12.5,
showing the origins of the extra-embryonic lineages and the components of the placenta. ICM, inner cell mass.
TROPHECTODERM
The outer epithelial layer of the
blastocyst.
BLASTOCYST
An early stage of mammalian
embryonic development at
which the first cell lineages
become established.
INNER CELL MASS 
(ICM).Asmall clump of
apparently undifferentiated cells
in the blastocyst, which gives rise
to the entire fetus plus some of
its extra-embryonic membranes.
IMPLANTATION
The process of embedding the
embryo into the lining of the
uterus.
EXTRA-EMBRYONIC ECTODERM
A diploid derivative of the early
postimplantation trophoblast,
which probably gives rise to the
labyrinthine trophoblast.
ECTOPLACENTAL CONE
A diploid derivative of the early
postimplantation trophoblast,
which probably gives rise to the
spongiotrophoblast.
ENDOREDUPLICATION
Repeated rounds of DNA
replication in the absence of
intervening mitoses, which lead
to polyploidy.
TROPHOBLAST GIANT CELLS
Non-dividing polyploid cells of
the rodent placenta that are
formed by endoreduplication.
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